{"id":52328,"date":"2022-12-23T13:02:07","date_gmt":"2022-12-23T12:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/"},"modified":"2022-12-23T13:02:07","modified_gmt":"2022-12-23T12:02:07","slug":"global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/","title":{"rendered":"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5701796\/global-dry-eye-disease-market-by-product-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=gxm738&amp;utm_campaign=1797357+-+Global+Dry+Eye+Disease+Market+to+Reach+%248.21+Billion+by+2028+at+a+CAGR+of+4.71%25&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Dry Eye Disease Market By product, By distribution channel &amp; By region-Forecast Analysis 2022-2028&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg\"><\/a><\/p>\n<p>\nGlobal Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR of 4.71% during the forecast period (2022- 2028).\n<\/p>\n<p>\nAccording to several research carried out all over the world, the prevalence of dry eye illness is thought to be between 8% and 34%. Ageing, diabetes, LASIK surgery, the use of specific drugs, and environmental factors like pollution are only a few of the related risk factors for dry eye disease. The demand for treatments and medications is influenced by these elements. Global geriatric population growth is predicted to result in an increase in the number of patients with dry eye disease.\n<\/p>\n<p>\n<strong>Segments covered in this report<\/strong>\n<\/p>\n<p>\nThe global dry eye disease market is segmented based on the product, distribution channel and region.\n<\/p>\n<ul>\n<li>\nBased on the product, it is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, and others.\n<\/li>\n<li>\nBased on distribution channel, it is segmented into hospital pharmacies, independent pharmacies &amp; drug stores, and online pharmacies.\n<\/li>\n<li>\nBased on region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.\n<\/li>\n<\/ul>\n<p>\n<strong>Driver<\/strong>\n<\/p>\n<p>\nThe market for dry eye disease is predicted to have strong growth during the assessment period of 2022-2028 due to the rise in the geriatric population and the rising number of eye-related ailments among them. The rising incidence of these disorders has compelled numerous researchers and developers to find effective treatment choices, which has ultimately enhanced the dry eye disease market&#8217;s growth prospects.\n<\/p>\n<p>\n<strong>Restraint<\/strong>\n<\/p>\n<p>\nFor the earliest stages of treating dry eye illness, many patients and doctors turn to over-the-counter artificial tears. A few somewhat pricey prescription drugs are recommended for the treatment of dry eye conditions. Additionally, these drugs only address the outward manifestations of dry eye illness; they do not address its underlying causes. These factors are likely to hinder market growth during the forecast period.\n<\/p>\n<p>\n<strong>Market Trends<\/strong>\n<\/p>\n<p>\nThe market for dry eye illness may have great growth prospects due to the increasing emergence of novel treatments as a result of intense research and development efforts. A significant growth driver for the dry eye disease market will be the rising public awareness of dry eye disease brought on by numerous government and non-government efforts. Furthermore, the market for dry eye disease will have strong development potential because of the speedy regulatory authority approval of novel treatment methods.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Market overview<\/strong>\n<\/p>\n<p>\n<strong>Parent Market Analysis<\/strong>\n<\/p>\n<p>\n<strong>Market overview<\/strong>\n<\/p>\n<p>\n<strong>Market size<\/strong>\n<\/p>\n<p>\n<strong>KEY MARKET INSIGHTS<\/strong>\n<\/p>\n<p>\n<strong>COVID IMPACT<\/strong>\n<\/p>\n<p>\n<strong>MARKET DYNAMICS &amp; OUTLOOK<\/strong>\n<\/p>\n<p>\n<strong>Global Dry Eye Disease Market by Product<\/strong>\n<\/p>\n<p>\n<strong>Global Dry Eye Disease Market by Distribution Channel<\/strong>\n<\/p>\n<p>\n<strong>Market Size by Region<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAllergan (Ireland)\n<\/li>\n<li>\nAlcon (Switzerland)\n<\/li>\n<li>\nNovartis AG (Switzerland)\n<\/li>\n<li>\nSanten Pharmaceutical Co., Ltd. (Japan)\n<\/li>\n<li>\nOASIS Medical (US)\n<\/li>\n<li>\nSun Pharmaceutical Industries Ltd (India)\n<\/li>\n<li>\nOtsuka Pharmaceutical Co., Ltd. (Japan)\n<\/li>\n<li>\nSentiss Pharma Pvt. Ltd. (India)\n<\/li>\n<li>\nJohnson &amp; Johnson Vision Care, Inc. (US)\n<\/li>\n<li>\nVISUfarma (Netherlands)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5701796\/global-dry-eye-disease-market-by-product-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=gxm738&amp;utm_campaign=1797357+-+Global+Dry+Eye+Disease+Market+to+Reach+%248.21+Billion+by+2028+at+a+CAGR+of+4.71%25&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/egewyu<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;p&#x72;e&#x73;s&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;&#97;r&#x6b;e&#x74;s&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#114;&#x65;s&#101;&#x61;r&#99;&#x68;&#97;&#x6e;&#x64;&#109;&#x61;&#x72;&#107;&#x65;t&#115;&#x2e;c&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Dry Eye Disease Market By product, By distribution channel &amp; By region-Forecast Analysis 2022-2028&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52328","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Dry Eye Disease Market By product, By distribution channel &amp; By region-Forecast Analysis 2022-2028&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-23T12:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-23T12:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/\"},\"wordCount\":574,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221223005122\\\/en\\\/1672463\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/\",\"name\":\"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221223005122\\\/en\\\/1672463\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-23T12:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221223005122\\\/en\\\/1672463\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221223005122\\\/en\\\/1672463\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Dry Eye Disease Market By product, By distribution channel &amp; By region-Forecast Analysis 2022-2028&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Dry Eye Disease Market size was valued at USD 5.95 billion in 2021, and it is expected to reach a value of USD 8.21 billion by 2028, at a CAGR ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-23T12:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% &#8211; ResearchAndMarkets.com","datePublished":"2022-12-23T12:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/"},"wordCount":574,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/","name":"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg","datePublished":"2022-12-23T12:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221223005122\/en\/1672463\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-dry-eye-disease-market-to-reach-8-21-billion-by-2028-at-a-cagr-of-4-71-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Dry Eye Disease Market to Reach $8.21 Billion by 2028 at a CAGR of 4.71% &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52328"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52328\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}